C07D 495/18
Bridged systems
C07D495/18 (Bridged systems) appears on 41 US grants and 59 published applications in this corpus.
Search patents in C07D- Granted patents
- 41
- Published applications
- 59
- Assignees
- 38
- Inventors
- 184
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 1 | 3 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 2 | 4 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 2 | 3 |
| 2012 | 0 | 2 |
| 2013 | 1 | 0 |
| 2014 | 2 | 2 |
| 2015 | 1 | 4 |
| 2016 | 4 | 4 |
| 2017 | 0 | 3 |
| 2018 | 1 | 2 |
| 2019 | 4 | 3 |
| 2020 | 2 | 6 |
| 2021 | 2 | 5 |
| 2022 | 1 | 2 |
| 2023 | 3 | 5 |
| 2024 | 2 | 3 |
| 2025 | 2 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Epoxide functionalized polyaromatic feedstock and polymers derived therefrom10 Mar 2026US 12,570,623 B2ExxonMobil Technology and Engineering Company
- Synthesis of cantharidin11 Feb 2025US 12,221,452 B2Verrica Pharmaceuticals Inc.
- Opioid receptor modulators14 Jan 2025US 12,195,478 B2The Trustees of Columbia University in the City of New York
- Fused pentacyclic imidazole derivatives27 Feb 2024US 11,912,721 B2Sanofi
- Heterocyclic compounds and their use in preventing or treating bacterial infections9 Jan 2024US 11,865,118 B2Mutabilis
- Nlrp3 modulators16 Jul 2026US 2026/0200935 A1Zomagen Biosciences Ltd
- Opioid receptor modulators17 Apr 2025US 2025/0122213 A1The Trustees of Columbia University in the City of New York
- Macrocyclic mcl-1 inhibitors and methods of use20 Mar 2025US 2025/0092062 A1AbbVie Deutschland GmbH & Co. KG
- Macrocyclic tak1 inhibitors22 Aug 2024US 2024/0279233 A1Aqilion AB
- Synthesis of cantharidin4 Apr 2024US 2024/0109911 A1Verrica Pharmaceuticals Inc.
Most cited
By later US patents
- Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities46US 5,373,093 A1994
- Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof12US 6,953,679 B2Bristol-Myers Squibb Company · 2005
- Compounds as cannabinoid receptor ligands10US 7,868,038 B2Abbott Laboratories · 2011
- Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function7US 7,141,578 B2Bristol-Myers Squibb Company · 2006
- 7,10-Dimethyl-5,9-imino-4,5,8,9-tetrahydro-cyclooct[b]thiophenes and a process for obtaining it5US 4,174,396 ALaboratories Made, S. A. · 1979